Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 06:13pm US/Eastern
   By Ben Fox Rubin 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at

Subscribe to WSJ:

React to this article
Latest news on JOHNSON & JOHNSON
1d ago JOHNSON & JOHNSON : Other Events, Financial Statements and Exhibits (form 8-K)
1d ago JOHNSON & JOHNSON : ex-dividend day
2d ago JOHNSON & JOHNSON : Congratulations to the 2014 Best Commitment to Education Pro..
2d ago JOHNSON & JOHNSON : Reasons for Optimism About West Virginia's Economy
2d ago JOHNSON & JOHNSON : Supply amendments mismatched components of the implant manuf..
2d ago JOHNSON & JOHNSON : Save the Children Named Johnson & Johnson's First 'Enterpris..
2d ago JOHNSON & JOHNSON : Announces Completion Of Alios BioPharma Acquisition
3d ago JOHNSON & JOHNSON : Investigators from Johnson & Johnson Have Reported New Data ..
3d ago JOHNSON & JOHNSON : Partners with Save the Children to Help Millions of Children..
3d ago JOHNSON & JOHNSON : Janssen Submits Application Seeking Approval Of SIMPONI® In ..
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes